Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

SmithKline Beecham patents novel ERK/MAP kinase inhibitors

Jan. 3, 2000

Phenylalanine derivatives selective for alpha4 integrins discovered by Celltech

Jan. 3, 2000

Preparation and use of MMP inhibitors described by Bayer

Jan. 3, 2000

Boston Life Sciences to meet with FDA regarding Therafectin

Dec. 30, 1999

New series of selectin inhibitors patented by Sumitomo

Dec. 29, 1999

Connetics completes patient enrollment in scleroderma pivotal trial

Dec. 28, 1999

Urea derivatives from Santen inhibit TNF-alpha production

Dec. 23, 1999

AstraZeneca discovers new cytokine inhibitors acting as p38 MAP kinase inhibitors

Dec. 21, 1999

Tetrapeptide with potent antiinflammatory, antiarthritic effects emerges from India

Dec. 20, 1999

Searle patents new series of p38 MAP kinase inhibitors for inflammation

Dec. 20, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...